Cargando…
Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease
Chronic liver disease leads to neuropsychiatric complications called hepatic encephalopathy (HE). Current treatments have some limitations in their efficacy and tolerability, emphasizing the need for alternative therapies. Modulation of gut bacterial flora using probiotics is emerging as a therapeut...
Autores principales: | Rackayová, Veronika, Flatt, Emmanuelle, Braissant, Olivier, Grosse, Jocelyn, Capobianco, Daniela, Mastromarino, Paola, McMillin, Matthew, DeMorrow, Sharon, McLin, Valérie A., Cudalbu, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838316/ https://www.ncbi.nlm.nih.gov/pubmed/33500487 http://dx.doi.org/10.1038/s41598-021-81871-8 |
Ejemplares similares
-
Longitudinal osmotic and neurometabolic changes in young rats with chronic cholestatic liver disease
por: Rackayova, Veronika, et al.
Publicado: (2020) -
Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE
por: Flatt, Emmanuelle, et al.
Publicado: (2021) -
Neurometabolic changes in a rat pup model of type C hepatic encephalopathy depend on age at liver disease onset
por: Simicic, Dunja, et al.
Publicado: (2023) -
The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy
por: Jaeger, Victoria, et al.
Publicado: (2019) -
Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice
por: McMillin, Matthew, et al.
Publicado: (2016)